K. M. Murphy and C. T. Weaver, Janeway's Immunobiology (Garland Science, 2016.

S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J Immunol, vol.155, pp.1151-1164, 1995.

S. Sakaguchi, Naturally arising Foxp3-expressing CD25 + CD4 + regulatory T cells in immunological tolerance to self and non-self, Nat Immunol, vol.6, pp.345-352, 2005.

R. K. Gershon, P. Cohen, R. Hencin, and S. A. Liebhaber, Suppressor T cells, J Immunol, vol.108, pp.586-590, 1972.

H. Groux, A CD4 + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, vol.389, pp.737-742, 1997.

D. Vignali, L. W. Collison, and C. J. Workman, How regulatory T cells work, Nat Rev Immunol, vol.8, pp.523-532, 2008.

R. M. Maizels and K. A. Smith, Regulatory T cells in infection, Adv Immunol, vol.112, pp.73-136, 2011.

Y. Takeuchi and H. Nishikawa, Roles of regulatory T cells in cancer immunity, Int Immunol, vol.28, pp.401-409, 2016.

N. Rivas, M. Chatila, and T. A. , Regulatory T cells in allergic diseases, J Allergy Clin Immunol, vol.138, pp.639-652, 2016.

A. J. Beres and W. R. Drobyski, The role of regulatory T cells in the biology of graftversus-host disease, Front Immunol, vol.4, p.163, 2013.

A. O'garra, P. L. Vieira, P. Vieira, and A. E. Goldfeld, IL-10-producing and naturally occurring CD4 + Tregs: Limiting collateral damage, J Clin Invest, vol.114, pp.1372-1378, 2004.

L. Buanec and H. , IFN-? and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells, Proc Natl Acad Sci, vol.108, pp.18995-19000, 2011.

S. Sarantopoulos, L. Lu, and H. Cantor, Qa-1 restriction of CD8 + suppressor T cells, J Clin Invest, vol.114, pp.1218-1221, 2004.

S. Hori, T. Nomura, and S. Sakaguchi, Control of regulatory T cell development by the transcription factor Foxp3, Science, vol.299, pp.1057-1062, 2003.

J. Wang, A. Ioan-facsinay, E. Van-der-voort, T. Huizinga, and R. Toes, Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells, Eur J Immunol, vol.37, pp.129-138, 2007.

M. Kmieciak, Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function, J Transl Med, vol.7, p.89, 2009.

M. Ayyoub, Human memory FOXP3 + Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t, Proc Natl Acad Sci, vol.106, pp.8635-8640, 2009.

G. Beriou, IL-17-producing human peripheral regulatory T cells retain suppressive function, Blood, vol.113, pp.4240-4249, 2009.

W. Chen, Conversion of peripheral CD4 + CD25 ? naive T cells to CD4 + CD25 + regulatory T cells by TGF-? induction of transcription factor Foxp3, J Exp Med, vol.198, pp.1875-1886, 2003.

S. G. Zheng, J. Wang, P. Wang, J. D. Gray, and D. A. Horwitz, IL-2 is essential for TGF-beta to convert naive CD4 + CD25 ? cells to CD25 + Foxp3 + regulatory T cells and for expansion of these cells, J Immunol, vol.178, pp.2018-2027, 2007.

M. Gliwi-nski, D. Iwaszkiewicz-grze-s, and P. Trzonkowski, Cell-based therapies with T regulatory cells, BioDrugs, vol.31, pp.335-347, 2017.

C. Baecher-allan, J. A. Brown, G. J. Freeman, and D. A. Hafler, CD4 + CD25 high regulatory cells in human peripheral blood, J Immunol, vol.167, pp.1245-1253, 2001.

S. Deaglio, Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression, J Exp Med, vol.204, pp.1257-1265, 2007.

A. Ohta and M. Sitkovsky, Extracellular adenosine-mediated modulation of regulatory T cells, Front Immunol, vol.5, p.304, 2014.

R. P. Dong, Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response, J Immunol, vol.156, pp.1349-1355, 1996.

C. B. Thompson, CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines, Proc Natl Acad Sci, vol.86, pp.1333-1337, 1989.

E. V. Acosta-rodriguez, G. Napolitani, A. Lanzavecchia, and F. Sallusto, Interleukins-1? and -6 but not transforming growth factor-? are essential for the differentiation of interleukin-17-producing human T helper cells, Nat Immunol, vol.8, pp.942-949, 2007.

C. Kemper, Activation of human CD4 + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype, Nature, vol.421, pp.388-392, 2003.

T. Graf and T. Enver, Forcing cells to change lineages, Nature, vol.462, pp.587-594, 2009.

U. Baron, DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells, Eur J Immunol, vol.37, pp.2378-2389, 2007.

H. Jonuleit, Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood, J Exp Med, vol.193, pp.1285-1294, 2001.

A. Ferraro, Interindividual variation in human T regulatory cells, Proc Natl Acad Sci, vol.111, pp.1111-1120, 2014.

S. Santegoets, Monitoring regulatory T cells in clinical samples: Consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry, Cancer Immunol Immunother, vol.64, pp.1271-1286, 2015.

J. Ogonek, Immune reconstitution after allogeneic hematopoietic stem cell transplantation, Front Immunol, vol.7, p.507, 2016.

S. Paust and H. Cantor, Regulatory T cells and autoimmune disease, Immunol Rev, vol.204, pp.195-207, 2005.

P. Trzonkowski, First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4 + CD25 + CD127 ? T regulatory cells, Clin Immunol, vol.133, pp.22-26, 2009.

M. Mandapathil, Generation and accumulation of immunosuppressive adenosine by human CD4 + CD25 high FOXP3 + regulatory T cells, J Biol Chem, vol.285, pp.7176-7186, 2010.